Senti Biosciences (SNTI) Earnings Date, Estimates & Call Transcripts $2.60 -0.26 (-9.09%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.66 +0.06 (+2.50%) As of 07:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Senti Biosciences Earnings Summary Senti Biosciences announced Q1 2025 earnings on May 6, 2025, reporting an EPS of -$1.41, which missed the consensus estimate of -$0.56 by $0.85. Quarterly revenue was reported to be $1.30 million, below analysts' expectations of $1.30 million. With a trailing EPS of -$10.84, Senti Biosciences' earnings are expected to grow next year, from ($14.54) to ($1.88) per share. Upcoming Q2 Earnings DateAug. 12EstimatedConsensus EPS (May. 6) -$0.56 Actual EPS (May. 6) -$1.41 Missed By -$0.85 Actual Revenue (May. 6) $1.30MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)SEC FilingSNTI Upcoming EarningsSenti Biosciences' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Powered by Get Senti Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Senti Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSNTI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNTI Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Senti Biosciences Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($14.54) EPSNext Year EPS Consensus Estimate ($1.88) EPS Senti Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/6/2025Q1 2025-$0.56-$1.41 -$0.85-$1.41$1.30M$1.30M3/20/2025Q4 2024-$3.13-$0.67+$2.46-$0.67$2.80M$5.86M8/13/2024Q2 2024--$2.45 -$2.45-$2.45--5/9/2024Q1 2024--$2.60 -$2.60-$0.26--3/21/2024Q4 2023--$4.20 -$4.20-$0.42--11/13/2023Q3 2023-$4.80-$2.50+$2.30-$0.16$0.94M$0.34M8/11/2023Q2 2023-$4.80-$4.20+$0.60-$0.42$1.29M$0.94M Senti Biosciences Earnings - Frequently Asked Questions When is Senti Biosciences' earnings date? Senti Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on SNTI's earnings history. Did Senti Biosciences beat their earnings estimates last quarter? In the previous quarter, Senti Biosciences (NASDAQ:SNTI) missed the analysts' consensus estimate of ($0.56) by $0.85 with a reported earnings per share (EPS) of ($1.41). Learn more on analysts' earnings estimate vs. SNTI's actual earnings. How can I view Senti Biosciences' earnings report? Senti Biosciences' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Senti Biosciences generate each year? Senti Biosciences (NASDAQ:SNTI) has a recorded annual revenue of $2.56 million. How much profit does Senti Biosciences generate each year? Senti Biosciences (NASDAQ:SNTI) has a recorded net income of -$71.06 million. SNTI has generated -$10.84 earnings per share over the last four quarters. What is Senti Biosciences' EPS forecast for next year? Senti Biosciences' earnings are expected to grow from ($14.54) per share to ($1.88) per share in the next year. More Earnings Resources from MarketBeat Related Companies Fulcrum Therapeutics Earnings Date iTeos Therapeutics Earnings Date Revance Therapeutics Earnings Date MBX Biosciences Earnings Date Checkpoint Therapeutics Earnings Date Rezolute Earnings Date Vigil Neuroscience Earnings Date Solid Biosciences Earnings Date ADC Therapeutics Earnings Date Aquestive Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:SNTI) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
